Furthermore, Xu and the colleagues have reported that the loss of PTEN in the prostate results in a substantial up-regulation of survivin expression that contributes to tumor development [56], suggesting that PI3K/Akt activity is critical to survivin expression. The gene discussed is BIRC5; the disease is neoplasm.